Why the study?
Does intracoronary methylene blue prevent the antiarrhythmic effect of ischaemic preconditioning in anaesthetized dogs?
Does intracoronary methylene blue prevent the antiarrhythmic effect of ischaemic preconditioning in anaesthetized dogs?
The antiarrhythmic effects of ischaemic preconditioning are completely reversed by methylene blue, suggesting mediation via guanylyl cyclase activation and increased cGMP levels.
Implicates cGMP pathway in canine preconditioning; leaves open translation to human antiarrhythmic strategies.
Short periods of coronary artery occlusion (2 x 5 min) markedly reduce the severity of arrhythmias and the changes in ST-segment elevation and in the degree of inhomogeneity of conduction during a subsequent 25 min occlusion of the left anterior descending coronary artery in anaesthetized dogs. These changes were completely reversed if methylene blue (5 mg min-1) was infused into a side branch of the coronary artery throughout both the preconditioning and prolonged occlusions. These results suggest that the pronounced antiarrhythmic effects of preconditioning result from activation of guanylyl cyclase and result in increased levels of guanosine 3':5'-cyclic monophosphate.
No takes yet. Share an insight, caveat, or question.
Végh et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: